On behalf of the ISNCC Board of Directors, it is with great regret that we announce that the International Conference on Cancer Nursing (ICCN 2020) will be postponed until early March 2021.
This decision was taken after close monitoring of the rising global risk assessment by the World Health Organization of the COVID19 outbreak. Although the risk of transmission of the COVID-19 Virus is currently assessed as moderate in the United Kingdom and enthusiasm for ICCN 2020 has remained high, the global situation is changing every day in unpredictable ways.
We recognize the need to care for the health and welfare of our participants and of the host community. We are cognizant of the travel restrictions that are being extended on a daily basis and impacting our colleagues’ ability to attend ICCN 2020 and we want to express our support for our colleagues who are in the frontlines of caring for their patients. We also are aware that health institutions, organisations and education facilities are restricting employees and students travel and participation in upcoming conferences.
ICCN2020 is proceeding as planned, and a great program is in place. ISNCC is aware of the global news regarding the Coronavirus (COVID) and the evolving travel advisories. At the moment, health authorities in the United Kingdom stated that risks to individuals in the UK remain low (https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-public). We’re following the guidance of the World Health Organization (WHO) and the UK Department of Health and Social Care. We will monitor the UK Foreign Office (https://www.gov.uk/foreign-travel-advice/china and communicate any changes for arrivals in the UK. Please note that many airports have added additional screening for visitors arriving from China and for those who have visited China recently.
As nurses we know, and the WHO reminds us, frequent hand washing with soap and water is the best way to prevent infections.
The International Society of Nurses in Cancer Care (ISNCC) has honored three outstanding nurses who have made substantial contributions to reducing the global burden of cancer.
Dr Stella Bialous, Past President of ISNCC and Chair of the Committee who oversees ISNCC’s Awards Program said “ISNCC is excited to recognize the extraordinary work of nurses who have made a major difference to cancer care. The successful applicants for this year’s awards are truly outstanding leaders whose work has led to advances in nursing practice as well as the development of nursing as a profession”.
Professor Theresa Wiseman, Strategic Lead for Applied Health Research at the Royal Marsden NHS Foundation Trust and Professor of Applied Health Research in Cancer Care at the University of Southampton, has been awarded ISNCC’s Distinguished Merit Award. This award is offered in recognition of an outstanding contribution to the international advancement of the science and art of cancer nursing. Professor Wiseman received the award in recognition of her leadership, education and research translating evidence into practice and significantly advancing cancer nursing and the development of cancer nurses. Her work has ensured better outcomes for people affected by cancer across many settings.
Dr Lena Sharp, Head of the Regional Cancer Centre, Stockholm-Gotland, in Sweden, has been awarded the prestigious Robert Tiffany Lectureship. This lectureship was created to keep alive the memory of Robert Tiffany, founding member and President of the International Society of Nurses in Cancer Care. Robert Tiffany was an inspiration to many nurses around the world and the intention of the named lecture is to honor those who have a similar capacity to inspire cancer nurses of today and of the future. Dr Sharp is a nurse who, in her long career, has inspired many nurses both in Sweden and internationally through her roles as an academic supervisor, colleague, leader/manager and President of the European Oncology Nursing Society (EONS).
The Past President’s award is especially important to the mission of ISNCC, as it is given in recognition of a cancer nurse from a low or middle-income country who has initiated and sustained a program of cancer care in her/his country. The program must have been in place for three or more years and has the potential for replication or adaptation beyond the country’s borders. This year, Mr David Makumi Kinyanjui, Vice-Chair of the Non-Communicable Diseases Alliance of Kenya, is the recipient of this award. David has made significant and unique contributions to shaping cancer nursing in Kenya and the region in his more than 15 years of cancer nursing at clinical practice, policy, and advocacy. He has held dual and unique roles, serving as the chair of the national umbrella body of over 30 cancer associations and patient groups (Kenya Network of Cancer Organizations) until July 2019, as well as a founding patron of the Oncology Nurses Chapter Kenya. David sits on the Board of the National Cancer Institute of Kenya a government agency that advises the Cabinet Secretary for Health on all cancer matters. His work over the last 3 years has focused on designing a framework of engagement between oncology nurses and cancer civil society organizations.
Distinguished Professor Patsy Yates, President of ISNCC,
said “The incidence of cancer worldwide
is expected to grow from 18.1 million in 2018 to 29.5 million in 2040. The
goals of reducing cancer incidence, improving survival, and providing better
palliative care cannot happen without the efforts of nurses. The work of the
three nurses who have received this year’s ISNCC awards provide excellent
examples of what can be done through nursing efforts.”
2020 has been designated by the World Health Organization as the International Year of the Nurse and Midwife. “Recognition of the work of these exceptional nurses is especially important as we begin our celebrations of the International Year of the Nurse and Midwife,” Professor Yates said.
ISNCC is the international membership organization of oncology nurse leaders dedicated to improving the health and well-being of people at risk for or living with cancer, promoting the nurse’s role in improving cancer care, and developing nursing leadership in cancer care delivery.
ISNCC was established in 1984 with a vision to lead the
global nursing community in cancer control and a mission to maximize the
influence of nursing to reduce the global burden of cancer.
For further information, please contact: Leya Duigu ISNCC Association Manager E: firstname.lastname@example.org T: +1 647.323.2152
Mark Foulkes RGN, BSc (Hons), MSc (Nurse Consultant and Macmillan Lead Cancer Nurse – Royal Berkshire NHS Foundation Trust)
Welcome to my latest blog in the run up to the ICCN 2020 in London, where I am giving our international guests a flavour of the main issues in UK oncology nursing.
“In line with many other countries, here in the UK we are experiencing increased demand for the delivery of SACT (Systemic Anti-Cancer Therapies) as the number of agents available becomes larger and more lines of therapy for patients with a cancer diagnosis are possible.”
This puts increasing demand upon our chemotherapy nurses and the skills that they need to utilise to keep patients safe. As a board member of the UK Oncology Nursing Society (UKONS) one of our proudest and most important achievements has been the development and implementation of thin e UKONS SACT Competence Passport (the Passport). This project has been led by Dr Catherine Oakley, Past President of UKONS and Chemotherapy Nurse Consultant at Guy’s and St Thomas’, London and received funding support from the Capital Nurse programme. The Passport is a patient-centered assessment document that ensures SACT clinicians demonstrate knowledge and skills to safely and autonomously administer SACT and care for patients receiving SACT.
Historically there was considerable
variation in the way chemotherapy nurses were trained to administer SACT and frequently
nurses in the UK had to repeat local training programmes when they changed
employer. Since 2017, the Passport has been implemented in SACT-provider
healthcare organisations throughout the UK, supported by ‘UKONS
In addition to the Passport, Dr Verna Lavender, UKONS President and Head of Guy’s Cancer Academy, published the UKONS SACT Competence Learning Outcomes Framework (the Framework) with Dr Oakley. The Framework is fully aligned to the Passport and was adopted by the National Health Service (NHS) in England in February 2019, so that on successful completion of the Passport clinicians working in the NHS can be added to the national SACT competence register. This allows SACT competent nurses to move between employers without needing to re-train. If you have registered or plan to register for ICCN 2020, and you wish to know more about teaching and assessment of SACT theory and practice in the UK, you can register to attend the UKONS Pre-Conference Program on 28 March 2020, which is free to ICCN2020 delegates. This full-day session is entitled ‘Standardising Systemic Anti-Cancer Therapy and Acute Oncology’ and will have a focus on the standardization of cancer services including sessions on the UKONS SACT Competence Passport and learning Outcomes Framework.
If you have registered or plan to register for ICCN 2020, and you wish to know more about teaching and assessment of SACT theory and practice in the UK, you can register to attend the UKONS Pre-Conference Program on 28 March 2020, which is free to ICCN 2020 delegates. This full-day session is entitled ‘Standardising Systemic Anti-Cancer Therapy and Acute Oncology’ and will have a focus on the standardization of cancer services including sessions on the UKONS SACT Competence Passport and learning Outcomes Framework. For more details, please visit the ICCN website. The UKONS SACT Competence Passport can be accessed here.
The UKONS SACT Competence Learning Outcomes framework accessed via the UKONS Website on the ‘SACT MIG pages’.
The purpose of the travel grants is to enable nurses from low and middle resource countries to attend the International Conference on Cancer Nursing (ICCN) 2020 from 29 March – 1 April 2020 in London, United Kingdom, and to participate in ISNCC meetings and activities.
The travel grants normally support travel, accommodation and registration for the conference.
Eligibility criteria for applicants:
Be a nurse working in cancer care
Be from a low or middle resource country (as defined by the World Bank)
Be free to travel to the country hosting the conference (London, UK).
Be able to acquire the necessary visa for the country hosting the conference
Have sufficiently fluent in English to understand the conference proceedings
Confirm that you are not receiving funding support to attend another ISNCC sponsored workshop associated with the conference
Requests for a travel scholarship may be made by self-nomination (application) or by nomination by a colleague.
Eligibility criteria for applicants:Nurses who have received an ISNCC travel grant within the previous four years will not be eligible to apply.
Only duly filled application forms will be considered. A letter of support from a national cancer nursing society or where one does not exist, from a national nursing society or a place of employment, is required.